• Affiliate Assistant Professor, Global Health
Photo of Anne Kasmar

Seattle, WA
United States

Download CV (11.67 KB)
Select from the following:
Biography 

Anne Kasmar joined the Bill & Melinda Gates foundation in 2015 as a Program Officer in the TB vaccine program. She received her undergraduate degree from Brown University and her medical degree from the University of California San Francisco. She was inspired to devote her career to TB while living in Southern Thailand as a Luce Scholar in 1998-9. She subsequently completed her internship and residency in internal medicine at the Massachusetts General Hospital before earning a masters' degree in the Immunology of Infectious Diseases at the London School of Hygiene and Tropical Medicine. She returned to the MGH for clinical infectious diseases fellowship as well as chief residency, after which she joined the laboratory of D. Branch Moody as a postdoctoral fellow. Her work at the bench focused on non-classically restricted T cells that target mycobacterial lipids presented by non-polymorphic CD1 molecules. In addition to making human CD1 tetramers for use in translational studies in Boston and at the KwaZulu Natal Research Institute for TB and HIV in Durban, South Africa, Anne was a BMGF grantee.

Education 
  • MD (University of California (San Francisco))
  • MSc (London School of Hygiene & Tropical Medicine (UK))
  • BA (Brown University)
Country Affiliations 
Languages 
  • French
  • German
  • Thai
Health Topics 
  • Infectious Diseases
  • TB
DGH Centers, Programs and Initiatives and Affiliated Organizations 
Publications 

Kasmar AG, van Rhijn I, Cheng TY, Turner MT, Seshadri C, Schiefner A, Kalathur RC, Annand JW, de Jong A, Shires J, Leon L, Brenner MB, Wilson IA, Altman JD, Moody DB. CD1b tetramers bind T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 2011 Aug 29;208(9):1741-7. PMID: 21807869 PMCID:PMC3171094

Kasprowicz, VO, Cheng TY, Ndung’u T, Sunpath H, Moody DB, Kasmar AG. HIV disrupts human T cells that target mycobacterial glycolipids. J Infect Dis 2016 Feb 15;213(4):628-33. doi: 10.1093/infdis/jiv455